Opportunity
SAM #DHA-JB-1
Procurement of Ortho Clinical Diagnostics VITROS 5600 Chemistry Analyzers, Reagents, and Support for U.S. Naval Hospital Naples
Buyer
Defense Health Agency
Posted
June 11, 2026
Respond By
June 30, 2026
Identifier
DHA-JB-1
NAICS
423450, 334516, 325413
The Defense Health Agency (DHA), for the U.S. Naval Hospital Naples, is seeking sources for the procurement and ongoing support of two Ortho Clinical Diagnostics VITROS 5600 chemistry analyzers and a comprehensive suite of associated reagents, consumables, and services. - Government Buyer: - Defense Health Agency (DHA) - U.S. Naval Hospital Naples - OEMs and Vendors: - Ortho Clinical Diagnostics (primary OEM for VITROS 5600 analyzers and most reagents/consumables) - Thermo Fisher Scientific (Thermo Scientific MAS quality control materials) - Products/Services Requested: - Two VITROS 5600 chemistry analyzers - Extensive list of reagents and consumables (e.g., glucose, BUN, creatinine, uric acid, bilirubin, cholesterol, electrolytes, calibrators, performance verifiers, maintenance packs) - Each with specified part numbers and quantities (e.g., 48 units of glucose reagent, part #1707801) - Thermo Scientific MAS quality control and calibration materials (multiple catalog numbers) - Full-risk maintenance contract for both analyzers, including application support, all product testing, and annual on-site training - Unique/Notable Requirements: - IDIQ contract structure with firm fixed price - All equipment, reagents, consumables, service, training, and shipping included - Detailed technical and operational requirements for analyzers and support - Annual on-site training and comprehensive application support - Contract period includes a base year plus four 12-month option years and an additional 6-month option
Description
See attached Sources Sought Notice for description of requirement and instructions for submitting a capability statement.